Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
a study on Head and Neck Squamous Cell Carcinoma Squamous Cell Carcinoma Cancer, General Head and Neck Cancer Cancer, Metastatic Tumor Tumor Recurrence Tumor Neck Tumor Metastasis Oral Cancer Oropharyngeal Cancer Oropharynx Cancer Oropharynx Cancer, Stage III Oropharynx Cancer, Recurrent Oropharynx Cancer, Metastatic Immunotherapy
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California
- Dates
- study startedestimated completion
- Principal Investigator
- Loren Mell, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at UCSD
- Loren Mell, MD
Professor In Residence, Radiation Medicine and Applied Science. Authored (or co-authored) 124 research publications. Research interests: Personalized Medicine · Clinical Trials · Risk Modeling · Immune System · Imaging · Immunotherapy
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Loren Mell, MD
- ID
- NCT03383094
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated